Abstract
Depression and anxiety are highly comorbid with chronic obstructive pulmonary disease (COPD) and are associated with poor treatment adherence, increased rates of physical disability, functional disability, mortality, healthcare costs, and a worsening quality of life. Despite its prevalence, there is a dearth of research on psychological treatments for depressed and/or anxious patients with COPD. This review examines the current evidence for psychological treatments for depression and anxiety in COPD, structured within the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework, in an effort to highlight the current practice and research needs for this important and complex patient population.
Keywords: Ambulatory care, anxiety, chronic obstructive pulmonary disease, depression, primary care, psychotherapy, REAIM
Current Respiratory Medicine Reviews
Title:Depression and Anxiety in Patients with COPD: A Focus on Psychological Treatments in Ambulatory Care Settings
Volume: 8 Issue: 2
Author(s): Joseph Mignogna, Jeffrey A. Cully
Affiliation:
Keywords: Ambulatory care, anxiety, chronic obstructive pulmonary disease, depression, primary care, psychotherapy, REAIM
Abstract: Depression and anxiety are highly comorbid with chronic obstructive pulmonary disease (COPD) and are associated with poor treatment adherence, increased rates of physical disability, functional disability, mortality, healthcare costs, and a worsening quality of life. Despite its prevalence, there is a dearth of research on psychological treatments for depressed and/or anxious patients with COPD. This review examines the current evidence for psychological treatments for depression and anxiety in COPD, structured within the RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework, in an effort to highlight the current practice and research needs for this important and complex patient population.
Export Options
About this article
Cite this article as:
Joseph Mignogna, Jeffrey A. Cully , Depression and Anxiety in Patients with COPD: A Focus on Psychological Treatments in Ambulatory Care Settings, Current Respiratory Medicine Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339812799859743
DOI https://dx.doi.org/10.2174/157339812799859743 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytoprotection and Immunomodulation in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance
Current Drug Targets Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia
Current Gene Therapy Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Role of Hexokinase and VDAC in Neurological Disorders
Current Molecular Pharmacology Regulation of Cardiac Nerves: A New Paradigm in The Management of Sudden Cardiac Death?
Current Medicinal Chemistry Yeast as a Powerful Model System for the Study of Apoptosis Regulation by Protein Kinase C Isoforms
Current Pharmaceutical Design Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug Targets Gene Patents in the Primary Prevention of Vascular Diseases
Recent Patents on DNA & Gene Sequences Application of NMR Metabolomics to Search for Human Disease Biomarkers
Combinatorial Chemistry & High Throughput Screening Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
Current Pharmaceutical Design B-Type Natriuretic Peptide for Diagnosis and Therapy
Recent Patents on Cardiovascular Drug Discovery Arterial Accelerated Aging in Dialysis Patients: The Clinical Impact of Vascular Calcification
Current Vascular Pharmacology Assessing Myocardial Metabolism with Hybrid PET Imaging: Instrumentation, Concepts, and Workflows
Current Pharmaceutical Design Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design A New Antitumor Agent, (3-chloro-7-methoxyfuro[2,3-b]-quinolin-4-yl)-(4-methoxyphenyl) amine, Loaded in Solid Lipid Nanoparticles: Characterization and Pharmacokinetics
Current Nanoscience Editorial: Inflammation and Heart Diseases
Current Pharmaceutical Design Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular Pharmacology Treatment of the Cheyne-Stokes Breathing Pattern in Patients with Congestive Heart Failure: State of the Art
Current Respiratory Medicine Reviews Therapeutic Approach for Neuronal Disease by Regulating Reninangiotensin System
Current Hypertension Reviews